FNDC5 and sarcopenia: Gaining a deeper understanding of the role and properties of irisin could pave the way for new therapeutic strategies for bone diseases, such as osteoporosis, while also identifying a new biomarker of the muscular state to facilitate diagnosis and consequently the timely initiation of therapy in patients with sarcopenia or muscle diseases.